Apollo Hospitals Enterprise Limited (APOLLOHOSP)
ISIN: - Industry: Medical Care Facilities Sector: Healthcare Website
4266.65
-39.1(-0.91%)

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide advanced healthcare services; and specialties in cardiac sciences, oncology, neurosciences, orthopedics, emergency, robotic surgery, and transplants. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. The company's footprint includes 9,911 beds, 4,529 pharmacies, and 1,734 national retail healthcare centers, as well as Apollo 24/7, an end-to-end omni-channel healthcare platform and www.apollopharmacy, an online pharmacy. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.

Pricing Updates

TODAY'S HIGH

4338.6

TODAY'S LOW

4250

52 WEEK HIGH

5935.4

52 WEEK LOW

3361.55

Major Holders

% of Shares Held by
All Insider

29.65%

% of Shares Held by
Institutions

48.56%

% of Float Held by
Institutions

69.03%

Number of Institutions
Holding Shares

244

Company Overview

MARKET CAP

61348.02 Cr.

ETERPRISE VALUE

62010.72 Cr.

NO. OF SHARES

14.37 Cr.

BOOK VALUE

391.092

DIV. YIELD

11.75%

DEBT

0

GROSS PROFIT

5130.90 Cr.

CASH

0

REVENUE

14689.40 Cr.

REVENUE/SHARE

1021.563

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-85.88 Cr.-1148.50 Cr.204.30 Cr.-53.40 Cr.
Change To Liabilities252.98 Cr.253.40 Cr.190.50 Cr.107.60 Cr.
Total cashflows from Investing Activities-790.73 Cr.-872.30 Cr.-288.80 Cr.-710.60 Cr.
Net Borrowings-346.96 Cr.-985.80 Cr.-186 Cr.234.80 Cr.
Total Cash from Financing Activities-767.70 Cr.-340.10 Cr.-909.50 Cr.-214.70 Cr.
Other Liabilities-230.15 Cr.299.40 Cr.-30.50 Cr.137.80 Cr.
Total Assets01170.10 Cr.1170.10 Cr.1170.10 Cr.
Net Income1055.61 Cr.150.40 Cr.454.90 Cr.236 Cr.
Change in Cash157.81 Cr.44.50 Cr.94.50 Cr.-20.10 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities1615.64 Cr.1273.40 Cr.1292.90 Cr.905.20 Cr.
Depreciation600.70 Cr.550.60 Cr.594.40 Cr.376.60 Cr.
Other Cashflows from Investing Activities35.94 Cr.21.80 Cr.15.50 Cr.14.80 Cr.
Dividends Paid-43.33 Cr.-38.30 Cr.-128.70 Cr.-83.70 Cr.
Change to Inventory-175.76 Cr.-94.60 Cr.-153.10 Cr.-18.90 Cr.
Change to Account Receivables-310.09 Cr.-530.30 Cr.-77.30 Cr.-272.50 Cr.
Other Cashflows from Financing Activities-377.41 Cr.-486.10 Cr.-594.80 Cr.-365.80 Cr.
Change to Net Income422.35 Cr.622 Cr.288.70 Cr.319.70 Cr.
Capital Expenditures-657.17 Cr.-295.50 Cr.-513 Cr.-678.90 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax1585.38 Cr.221.50 Cr.657 Cr.373.50 Cr.
Minority Interest254.33 Cr.199.90 Cr.130.70 Cr.135.50 Cr.
Net Income1662.56 Cr.567.20 Cr.971.30 Cr.674.20 Cr.
Selling General Administrative0263.50 Cr.334.80 Cr.547.60 Cr.
Gross Profit5380.79 Cr.3139.60 Cr.3767.20 Cr.3257.70 Cr.
Ebit1662.56 Cr.567.20 Cr.971.30 Cr.674.20 Cr.
Operating Income1662.56 Cr.567.20 Cr.971.30 Cr.674.20 Cr.
Other Operating Expenses3117.53 Cr.1735.80 Cr.1841.40 Cr.1640.40 Cr.
Interest Expense-378.64 Cr.-405.80 Cr.-463.30 Cr.-283.70 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense477.02 Cr.84.70 Cr.225.20 Cr.173.40 Cr.
Total Revenue14740.78 Cr.10560 Cr.11246.80 Cr.9617.50 Cr.
Total Operating Expenses13078.22 Cr.9992.80 Cr.10275.50 Cr.8943.30 Cr.
Cost of Revenue9359.99 Cr.7420.40 Cr.7479.60 Cr.6359.80 Cr.
Total Other Income Expense Net-77.18 Cr.-345.70 Cr.-314.30 Cr.-300.70 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.1108.36 Cr.136.80 Cr.431.80 Cr.200.10 Cr.
Net Income Applicable to Common Shares1055.61 Cr.150.40 Cr.454.90 Cr.236 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets107.85 Cr.85.90 Cr.54.70 Cr.35.10 Cr.
Capital Surplus02863.70 Cr.1713.90 Cr.1713.90 Cr.
Total Liabilities7314.73 Cr.6614.30 Cr.7868.70 Cr.5714.10 Cr.
Stock Holder Equity5645.15 Cr.4602.50 Cr.3339 Cr.3333.50 Cr.
Minority Interest254.33 Cr.199.90 Cr.130.70 Cr.135.50 Cr.
Other Liabilities443.80 Cr.249.10 Cr.291.70 Cr.326.70 Cr.
Total Assets13214.21 Cr.11416.70 Cr.11338.40 Cr.9183.10 Cr.
Common Stock71.89 Cr.71.90 Cr.69.60 Cr.69.60 Cr.
Retained Earnings01718 Cr.1551.30 Cr.1495.40 Cr.
Other Liabilities1171 Cr.873.10 Cr.811.90 Cr.806.60 Cr.
Good Will923.49 Cr.375.30 Cr.346.20 Cr.346.20 Cr.
Treasury Stock5573.26 Cr.-51.10 Cr.4.20 Cr.54.60 Cr.
Other Assets482.22 Cr.423.60 Cr.670.50 Cr.711.70 Cr.
Cash1035.87 Cr.425.20 Cr.380.70 Cr.286.20 Cr.
Current Liabilities2383.17 Cr.2037.80 Cr.2337.30 Cr.1955.40 Cr.
Long Term Asset Charges8.32 Cr.25.10 Cr.49.60 Cr.17.40 Cr.
Short Long Term Debt0364.70 Cr.246 Cr.221 Cr.
Other Stockholder Equity5573.26 Cr.-51.10 Cr.4.20 Cr.54.60 Cr.
Property Plant Equipment7278.94 Cr.6545.70 Cr.7260.90 Cr.5415.60 Cr.
Total Cur. Assets4121.42 Cr.3641.30 Cr.2646.90 Cr.2281.70 Cr.
Long Term Investments300.29 Cr.344.90 Cr.359.20 Cr.392.80 Cr.
Net Tangible Assets4613.81 Cr.4141.30 Cr.2938.10 Cr.2952.20 Cr.
Short Term Investments501.34 Cr.000
Net Receivables1904.81 Cr.1488.90 Cr.1192.80 Cr.1145.80 Cr.
Long Term Debt2427.22 Cr.2473.40 Cr.2852 Cr.2951.40 Cr.
Inventory431.77 Cr.249.50 Cr.737.80 Cr.584.80 Cr.
Accounts Payable1631.81 Cr.1160 Cr.908.80 Cr.713.10 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account